Renate van den Doel

BS, Biomedical Sciences, Leiden University, 2022

While working in the lab of Hidde Ploegh in Boston during my final year in the biomedical sciences program at Leiden University, I characterized nanobodies with therapeutic potential in autoimmune disease and tested them in animal models.

In the Littman lab, I am interested in studying interactions between the immune system and the nervous system in different inflammatory states.

 

Publications:

  1. Pishesha N, Harmand T, Carpenet C, Liu X, Bhan A, Islam A, van den Doel R, et al. Targeted delivery of an anti-inflammatory corticosteroid to Ly6C/G-positive cells abates severity of influenza A symptoms. Proc Natl Acad Sci. 2022 Oct 25;119(43):e2211065119

  2. Pishesha N, Harmand TJ, Rothlauf PW, Praest P, Alexander RK, van den Doel R, et al. A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants. Proc Natl Acad Sci U S A. 2021 Nov 2;118(44):e2116147118